← Back to Clinical Trials
Recruiting NCT06322888

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Trial Parameters

Condition Breast Cancer
Sponsor Dana-Farber Cancer Institute
Study Type INTERVENTIONAL
Phase N/A
Enrollment 46
Sex FEMALE
Min Age 18 Years
Max Age 59 Years
Start Date 2024-03-28
Completion 2026-09-30
Interventions
Exercise Training Program

Brief Summary

The goal of this study is to learn more about how exercise might lower the risk of developing breast cancer in women with dense breast tissue by studying changes that occur in breast tissue and blood as a result of participating in an exercise program. The names of the study groups in this study are: * Exercise Training Group * Waitlist Control Group

Eligibility Criteria

Inclusion Criteria: * Women aged 18-59 * Heterogeneously dense/extremely dense (BIRADS 3 or 4) breast tissue on mammogram within the past 12 months * Physically inactive; engaging in \<60 minutes of moderate or vigorous intensity exercise per week, as assessed by Godin Leisure Time screener * Not pregnant or breastfeeding * English speaking and able to read English. Investigators are only enrolling English-speaking participants to this study at this time due to the fact that investigators currently only have English-speaking exercise trainers with the proper qualifications to conduct the exercise training * Written informed consent prior to any study-related procedures Exclusion Criteria: * Self-reported inability to walk 2 blocks (at any pace) * Prior history of breast cancer; prior DCIS is allowable as long as participant is not taking endocrine therapy and has at least 1 breast that has not been irradiated * On oral or implantable hormonal contraceptives, postmenopausal hormone repl

Related Trials